<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36610599</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Previously independent patients with mild-symptomatic COVID-19 are at high risk of developing cognitive impairment but not depression or anxiety.</ArticleTitle><Pagination><StartPage>645</StartPage><EndPage>651</EndPage><MedlinePgn>645-651</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2022.12.100</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(22)01461-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The aim of the study was to explore the cognitive functions of a large sample of hospitalised subjects with mild symptomatic Coronavirus Disease (COVID-19) who were previously independent at home and without neurological diseases.</AbstractText><AbstractText Label="METHODS">Patients admitted in a COVID-19 Unit for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection between November 2020 and March 2021 were recruited. Inclusion criteria were: being independent at home before the infection, radiologically confirmed COVID-19 pneumonia, positive reverse transcriptase-polymerase chain reaction nasopharyngeal swab and no oxygen supplementation at the time of evaluation.</AbstractText><AbstractText Label="EXCLUSION CRITERIA">cognitive impairment or neurological diseases previous to the infection, delirium episodes, and history of any mechanical ventilation use. They were evaluated with Montreal Cognitive Assessment (MoCA), Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A).</AbstractText><AbstractText Label="RESULTS">Out of 522 subjects admitted in the COVID-19 Unit, 90 were enrolled [mean age&#xa0;=&#xa0;68.32(11.99); 46M/44F]. An impaired MoCA (cut-off&#xa0;&lt;&#xa0;23) was found in 60 subjects (66.66&#xa0;%). Pathological scores were obtained by 36.7&#xa0;% of the subjects with &lt;65&#xa0;years and 78.3&#xa0;% of those older than 65&#xa0;years. A high prevalence of executive function and memory impairment was detected.</AbstractText><AbstractText Label="CONCLUSIONS">The results underline a high rate of cognitive impairment in previously independent mild COVID-19 patients. This might represent a potential threat for the everyday independence of these patients due to the consequences on everyday life activities and work following discharge from hospital. These subjects should, therefore, be monitored in order to allow a better understanding of the progression and consequences of the so-called "Long COVID".</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gamberini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Moncrivello, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuccio</LastName><ForeName>Fabio Giuseppe</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Moncrivello, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrato</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Moncrivello, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strazzacappa</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Moncrivello, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Universit&#xe0; degli Studi di Modena e Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solaro</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Moncrivello, Italy. Electronic address: csolaro@libero.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive function</Keyword><Keyword MajorTopicYN="N">MoCA</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare no conflict of interest relevant to this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36610599</ArticleId><ArticleId IdType="pmc">PMC9812466</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2022.12.100</ArticleId><ArticleId IdType="pii">S0165-0327(22)01461-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carda S., Invernizzi M., Bavikatte G., Bensmail D., Bianchi F., Deltombe T., Draulans N., Esquenazi A., Francisco G.E., Gross R., Jacinto L.J., Moraleda Perez S., O&#x2019;Dell M.W., Reebye R., Verduzco-Gutierrez M., Wissel J., Molteni F. The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician's view. Ann. Phys. Rehabil. Med. 2020;63:554&#x2013;556. doi: 10.23736/S1973-9087.20.06317-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06317-0</ArticleId><ArticleId IdType="pmc">PMC7166018</ArticleId><ArticleId IdType="pubmed">32315802</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson N., Leach L., Murphy K.J. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int. J. Geriatr. Psychiatry. 2018;33:379&#x2013;388. doi: 10.1002/gps.4756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4756</ArticleId><ArticleId IdType="pubmed">28731508</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Laurent S., Onur O.A., Kleineberg N.N., Fink G.R., Schweitzer F., Warnke C. A systematic review of neurological symptoms and complications of COVID-19. J. Neurol. 2020;268:392&#x2013;402. doi: 10.1007/s00415-020-10067-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10067-3</ArticleId><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti S., Bonazzi S., Laiacona M., Masina M., Coralli M.V. Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores. Neurol. Sci. 2015;36:209&#x2013;214. doi: 10.1007/s10072-014-1921-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-014-1921-3</ArticleId><ArticleId IdType="pubmed">25139107</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Pietra G.L., Savio K., Oddone E., Reggiani M., Monaco F., Leone M.A. Validity and reliability of the Barthel Index administered by telephone. Stroke. 2011;42:2077&#x2013;2079. doi: 10.1161/STROKEAHA.111.613521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.613521</ArticleId><ArticleId IdType="pubmed">21527755</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeoto G., Lauta A., Palumbo A., Castiglia S., Mollica R., Santilli V., Sacchetti M. The Barthel Index: Italian translation, adaptation and validation. Int. J. Neurol. Neurother. 2015;2:1&#x2013;7. doi: 10.23937/2378-3001/2/2/1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2378-3001/2/2/1028</ArticleId><ArticleId IdType="pmc">PMC4674830</ArticleId><ArticleId IdType="pubmed">26658924</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., Freedberg D.E., Kirtane A.J., Parikh S.A., Maurer M.S., Nordvig A.S., Accili D., Bathon J.M., Mohan S., Bauer K.A., Leon M.B., Krumholz H.M., Uriel N., Mehra M.R., Elkind M.S.V., Stone G.W., Schwartz A., Ho D.D., Bilezikian J.P., Landry D.W. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56&#x2013;62. doi: 10.1136/jnnp.23.1.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., Thurow J., Wagner D., Waller C., Niesen W.D., Frings L., Urbach H., Prinz M., Weiller C., Schroeter N., Meyer P.T. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;1&#x2013;14 doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Gottesman R.F. Neurovascular and cognitive dysfunction in hypertension. Circ. Res. 2019;124:1025&#x2013;1044. doi: 10.1161/CIRCRESAHA.118.313260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313260</ArticleId><ArticleId IdType="pmc">PMC6527115</ArticleId><ArticleId IdType="pubmed">30920929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin. Infect. Dis. 2021;1&#x2013;35 doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel Index. Md. State Med. J. 1965;14:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K., Johnsen S., Sattler S., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., B&#xc3;&#xa9;dirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D.L., Kumar G., Raftopoulos R.E., Zambreanu L., Vivekanandam V., Khoo A., Geraldes R., Chinthapalli K., Boyd E., Tuzlali H., Price G., Christofi G., Morrow J., McNamara P., McLoughlin B., Lim S.T., Mehta P.R., Levee V., Keddie S., Yong W., Trip S.A., Foulkes A.J.M., Hotton G., Miller T.D., Everitt A.D., Carswell C., Davies N.W.S., Yoong M., Attwell D., Sreedharan J., Silber E., Schott J.M., Chandratheva A., Perry R.J., Simister R., Checkley A., Longley N., Farmer S.F., Carletti F., Houlihan C., Thom M., Lunn M.P., Spillane J., Howard R., Vincent A., Werring D.J., Hoskote C., J&#xe4;ger H.R., Manji H., Zandi M.S. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O., Lui L.M.W., Eskander S., Ceban F., Ho R., Di Vincenzo J.D., Rosenblat J.D., Lee Y., Subramaniapillai M., McIntyre R.S. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J. Psychiatr. Res. 2021;144:129&#x2013;137. doi: 10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Chan D., Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020;2:1&#x2013;5. doi: 10.1093/braincomms/fcaa069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa069</ArticleId><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G., Siciliano M., Pedone R., Vitale C., Falco F., Bisogno R., Siano P., Barone P., Grossi D., Santangelo F., Trojano L. Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol. Sci. 2015;36:585&#x2013;591. doi: 10.1007/s10072-014-1995-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-014-1995-y</ArticleId><ArticleId IdType="pubmed">25380622</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E. Hamilton rating scale for anxiety (HAM-A) Occup. Med. 2015;65:601. doi: 10.1093/occmed/kqv054. (Chic. Ill)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqv054</ArticleId><ArticleId IdType="pubmed">26370845</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO; Geneva: 1999. Men Ageing And Health.</Citation></Reference><Reference><Citation>Yeung P.Y., Wong L.L.L., Chan C.C., Yung C.Y., Leung L.M.J., Tam Y.Y., Tang L.N., Li H.S., Lau M.L. Montreal cognitive assessment &#x2014; single cutoff achieves screening purpose. Neuropsychiatr. Dis. Treat. 2020;16:2681&#x2013;2687. doi: 10.2147/NDT.S269243.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S269243</ArticleId><ArticleId IdType="pmc">PMC7656779</ArticleId><ArticleId IdType="pubmed">33192067</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>